New blood test spots silent spread of bile duct cancer before surgery
NCT ID NCT07224737
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a blood test that looks at tiny particles called exosomes can find cancer that has spread but is not visible on scans in people with a type of bile duct cancer (intrahepatic cholangiocarcinoma). The goal was to help doctors know who needs stronger treatment before surgery. 230 patients who had surgery provided blood samples, and the results were analyzed using machine learning to predict the risk of hidden spread.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spirulina's secret protein may shield the liver during surgery
- New drug cocktail aims to outsmart untreatable bile duct cancer
- AI could spot liver cancer types and predict survival without needle biopsy
- New drug cocktails aim to stop bile duct cancer return after surgery
- New cocktail of Liver-Directed chemo and immunotherapy targets deadly bile duct cancer
- Anti-Inflammatory drug may boost cancer therapy in bile duct cancer